Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference
Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis.
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Immunopathology of multiple sclerosis.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Laquinimod Halted MS Disability But Not Relapses
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Naltrexone
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.

Pages